Market Access
-
{
- All
- News
- Videos
-
Ethereum NFT Platform Shuts Down After Blacklove Sale Falls Through
Ethereum-based NFT platform Foundation is shutting down after a planned acquisition by Blackdove fell through. The move reflects ongoing challenges in the NFT market, even as trading activity continues. Users will be allowed to withdraw and delist assets before the platform fully ceases operations.
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
Apple Seeks Samsung South Korea’s Internal Records as App Store Practices Face DOJ Antitrust Scrutiny: Report
Apple has reportedly approached a US court to secure internal documents from Samsung Electronics in South Korea. The move is said to be linked to the ongoing antitrust lawsuit brought by the US Department of Justice (DOJ). The Cupertino-based tech giant seeks access to market data and internal business records, which it maintains are vital for its ...
-
'Peak Bengaluru': Autorickshaw Driver Tracks Crypto Charts At Traffic Signal
An autorickshaw driver in Bengaluru trades crypto and uses Google Maps simultaneously at a traffic signal.
-
UK Conservatives Echo Trump's Rhetoric To Push For North Sea Drilling
British conservatives are seeking to remove barriers to oil and gas drilling in the North Sea to facilitate access to domestic fossil fuel resources.
-
Pradhan Mantri Jan Aushadhi Pariyojana Expands Access For People In Dumka, Jharkhand
Dumka (Jharkhand), March 19 (IANS) People in Jharkhand's Dumka district are purchasing medicines at affordable rates from a pharmacy centre operating under the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana, bringing significant relief to poor and u
-
Affordable Semaglutide Is Coming: Should You Be Worried About Drug Safety, Health Risks And Side Effects?
India's healthcare landscape will change as semaglutide patents expire in 2026, allowing over 50 generic versions to enter the market and improve access for diabetes and obesity treatment.
-
Ozempic's Key Molecule To Go Off-Patent: What Changes Now?
Patent protections on semaglutide, developed by Novo Nordisk, will lapse on March 20, opening the door for domestic pharmaceutical companies to manufacture and sell their own versions of the drug.
-
Argentina Bans Polymarket Over Unregulated Crypto Betting Concerns: Report
Argentina has blocked access to crypto-based prediction platform Polymarket, saying it operates outside the country’s regulated gambling and financial systems. Regulators flagged risks related to consumer protection and oversight, adding to growing global scrutiny of prediction markets using digital assets.
-
Abbott, Novo Nordisk India Partner Up To Launch Second Brand Of Ozempic, Widen Access To Diabetes Drug
Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, Extensior, in India
-
Ethereum NFT Platform Shuts Down After Blacklove Sale Falls Through
Ethereum-based NFT platform Foundation is shutting down after a planned acquisition by Blackdove fell through. The move reflects ongoing challenges in the NFT market, even as trading activity continues. Users will be allowed to withdraw and delist assets before the platform fully ceases operations.
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
Apple Seeks Samsung South Korea’s Internal Records as App Store Practices Face DOJ Antitrust Scrutiny: Report
Apple has reportedly approached a US court to secure internal documents from Samsung Electronics in South Korea. The move is said to be linked to the ongoing antitrust lawsuit brought by the US Department of Justice (DOJ). The Cupertino-based tech giant seeks access to market data and internal business records, which it maintains are vital for its ...
-
'Peak Bengaluru': Autorickshaw Driver Tracks Crypto Charts At Traffic Signal
An autorickshaw driver in Bengaluru trades crypto and uses Google Maps simultaneously at a traffic signal.
-
UK Conservatives Echo Trump's Rhetoric To Push For North Sea Drilling
British conservatives are seeking to remove barriers to oil and gas drilling in the North Sea to facilitate access to domestic fossil fuel resources.
-
Pradhan Mantri Jan Aushadhi Pariyojana Expands Access For People In Dumka, Jharkhand
Dumka (Jharkhand), March 19 (IANS) People in Jharkhand's Dumka district are purchasing medicines at affordable rates from a pharmacy centre operating under the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana, bringing significant relief to poor and u
-
Affordable Semaglutide Is Coming: Should You Be Worried About Drug Safety, Health Risks And Side Effects?
India's healthcare landscape will change as semaglutide patents expire in 2026, allowing over 50 generic versions to enter the market and improve access for diabetes and obesity treatment.
-
Ozempic's Key Molecule To Go Off-Patent: What Changes Now?
Patent protections on semaglutide, developed by Novo Nordisk, will lapse on March 20, opening the door for domestic pharmaceutical companies to manufacture and sell their own versions of the drug.
-
Argentina Bans Polymarket Over Unregulated Crypto Betting Concerns: Report
Argentina has blocked access to crypto-based prediction platform Polymarket, saying it operates outside the country’s regulated gambling and financial systems. Regulators flagged risks related to consumer protection and oversight, adding to growing global scrutiny of prediction markets using digital assets.
-
Abbott, Novo Nordisk India Partner Up To Launch Second Brand Of Ozempic, Widen Access To Diabetes Drug
Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, Extensior, in India
